CREATING A NEW VISION

LENTECHS is a privately-held, clinical-stage, ophthalmic medical device company in Columbus, Ohio dedicated to improving vision at every stage of life through innovative design and breakthrough contact lens technology. LENTECHS is focused on developing a patented, first-of-its-kind line of soft, suspended contact lens designed to deliver exceptional, glasses-like vision at all distances.

Vision solutions for life

Lentechs is focused on the 120 million US patients and 2 billion worldwide living with presbyopia. The majority of these patients wear spectacles but would prefer to wear contact lenses and, among these patients who do wear contact lenses, many do not receive the desired results from currently available technology.

LENTECHS has created a new generation of soft, suspended contact lens, designed to deliver exceptional, glasses-like vision at all distances. The contact lens is first and foremost, designed to utilize the eye’s anatomy rather than conform to it. Unlike traditional contact lenses, it is suspended behind the upper eyelid, allowing for free, translational (up and down) eye movement, behind the rotationally-stable, centered contact lens. By allowing the eye to freely move behind the contact lens, wearers can access the specific prescription needed for each visual distance correction.

Patented vision solutions

LENTECHS has patented its front-to-back lens innovations designed to deliver unique vision solutions in soft contact lenses.

Patents Granted

Contact lens comprising lenticular-like curve: USPTO #10,191,302

Contact lens comprising a superior lenticular aspect: USPTO #10,598,957

Contacts lens comprising a lenticular in a superior portion of the contact lens: USPTO #11,022,816

Contact lens comprising lenticular-like curve: USPTO #11,022,817

Soft contact lens comprising a lenticular in a superior portion of the contact lens with enhanced tear exchange: USPTO #11,320,673

Additionally, 38 global patents have issued

Collaboration minded. Innovation focused.

LENTECHS has successfully developed core technology licensed from The Ohio State Innovation Foundation.

PRESIDENT AND CEO

Robin Sears

CHIEF MEDICAL OFFICER

Joe Barr, OD, MS, FAAO

CHIEF COMMERCIAL OFFICER

Paul Grimm

CHIEF FINANCIAL OFFICER

Brad Beasecker

Get in touch with LENTECHS

Question or comments? We want to hear from you.

The statements on this website have not been evaluated by the FDA, and the device is not currently available for purchase or use in the United States.